Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1998-11-13
2000-05-23
Morris, Patricia L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514292, 544126, 546 86, 546 87, A61K 315377, A61K 314523, C07D48744
Patent
active
060666331
ABSTRACT:
Compound of formula (I): ##STR1## in which: m represents an integer from 1 to 4 inclusive, and n and p an integer from 0 to 4 inclusive,
REFERENCES:
patent: 5643916 (1997-07-01), Audin et al.
Harris, Adrian L., "Antiangiogenesis for Cancer Therapy", The Lancet, vol. 349 (1997) pp. 13-15.
Skobe, Mihaela, et al., "Halting Angiogenesis Suppresses Carcinoma Cell Invasion", Nature Medicine, vol. 3 No. 11, (1997) pp. 1222-1227.
Kleiner, David E., et al., "Matrix Metalloproteinases and Metastasis", Cancer Chemother Pharmacol, vol. 43 (Suppl) (1999) pp. S42-S51.
Nemunaitis, John et al., "Combined Analysis of Studies of the Effects of the Matrix Metallo-proteinase Inhibitor Marimastat on Serum Tumor Markers in Advanced Cancer: Selection of a Biologically Active and Tolerable Dose for Longer-Term Studies", Clinical Cancer Research, vol. 4 (1998) pp. 1101-1109.
Steward, William P., "Marimastat (BB2516): Current Status of Development", Cancer Chemother Pharnacol, vol. 43 (Suppl) (1999) pp. S56-S60.
Atassi Ghanem
Bonnet Jacqueline
De Nanteuil Guillaume
Paladino Joseph
Pierre Alain
Adir et Compagnie
Morris Patricia L.
LandOfFree
Metalloproteinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Metalloproteinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Metalloproteinase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1837251